3rd Circ. Upholds Class Cert. Denial In Niaspan MDL
By Piper Hudspeth Blackburn ( May 5, 2023, 10:04 PM EDT) -- The Third Circuit has upheld a Pennsylvania federal court's denial of class certification to a group of union insurance plans that claimed AbbVie Inc. paid to delay a generic version of the cholesterol drug Niaspan....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.